filmov
tv
Dr. Bekaii-Saab on Moving Metastatic Treatment Strategies to the Adjuvant Setting in CRC
Показать описание
OncLive
cancer
oncology
Рекомендации по теме
0:01:45
Dr. Bekaii-Saab on Moving Metastatic Treatment Strategies to the Adjuvant Setting in CRC
0:03:47
Dr Bekaii-Saab on the Future of Treatment For Patients With GI Cancer
1:00:44
Recent Advances and Future Directions in Gastrointestinal Cancers — With Dr Tanios Bekaii-Saab an......
0:01:20
Dr. Bekaii-Saab on the Use of Regorafenib in Patients With mCRC
0:04:24
The Current Paradigm of Metastatic Colorectal Cancer
0:10:42
ASCO 2018: Dr. Bekaii-Saab Highlights Pancreatic Cancer Abstracts
0:25:11
Unpacking the Treatment Algorithm of Hepatocellular Carcinoma with Dr. Tanios S. Bekaii-saab
0:05:15
Multidisciplinary Care in Metastatic Colorectal Cancer
0:05:31
Later Lines of Therapy for Metastatic Colorectal Cancer
0:01:42
Dr. Bekaii-Saab on the APACT Trial in Pancreatic Cancer
0:06:00
Metastatic Colorectal Cancer: Multiple Lines of Therapy
0:05:53
ReDOS Trial: Optimizing Regorafenib Dosing in metastatic Colorectal Cancer
0:01:58
Dr. Bekaii-Saab Discusses the Evolution of Treatment for Pancreatic Cancer
0:01:13
Dr. Bekaii-Saab on the Potential Impact of Napabucasin Combo in Pancreatic Cancer
0:01:39
Dr. Bekaii-Saab on Dosing Strategies With Regorafenib in CRC
0:01:50
Dr. Bekaii-Saab on Sequencing Regorafenib and TAS-102 in CRC
0:03:59
Liver-Directed Therapies in Metastatic Colorectal Cancer
0:00:57
Dr. Bekaii-Saab Discusses the Next Steps With Regorafenib in CRC
0:02:02
Tanios Bekaii-Saab, MD: Impact of Third-Line Therapy
0:32:21
Emerging Role of HER2-Targeted Therapy in BTCs — Tanios Bekaii-Saab, MD
0:15:52
Debate: Are novel targets such as HER2 ready for prime time in colorectal cancer? - No
0:03:16
Tanios Bekaii-Saab, MD, discusses oral chemo in adjuvant and advanced CRC treatment during COVID
0:01:49
Dr. Bekaii-Saab on Resistance to Targeted Therapy in CRC
0:06:09
Key points to consider when determining the best treatment for advanced metastatic pancreatic cancer